Robles BioCeutics Appoints Renowned Stem Cell Drug Developer Jorge Genovese, MD, Ph.D., as Chief Scientific Officer

Leading Regenerative Dermatology Company Gears Up for Accelerated Clinical Translation of Stem Cell-Based Dermatology Pipeline SAN DIEGO, Dec. 4, 2024 /PRNewswire/ — Robles BioCeutics, a science-driven regenerative dermatology company, announced today the appointment of Jorge Genovese,…